JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 15, 2005; DOI: 10.1124/jpet.105.094391


0022-3565/06/3171-109-116$20.00
JPET 317:109-116, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.094391v1
317/1/109    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, L.
Right arrow Articles by Yu, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, L.
Right arrow Articles by Yu, S. P.
Right arrowPubmed/NCBI databases
*Substance via MeSH

NEUROPHARMACOLOGY

Cell Death Mechanism and Protective Effect of Erythropoietin after Focal Ischemia in the Whisker-Barrel Cortex of Neonatal Rats

Ling Wei, Byung H. Han, Ying Li, Christine L. Keogh, David M. Holtzman, and Shan Ping Yu

Departments of Pathology and Laboratory Medicine (L.W., Y.L., C.L.K., S.P.Y.) and Pharmaceutical Sciences (S.P.Y.), Medical University of South Carolina, Charleston, South Carolina; Department of Neurology, Molecular Biology and Pharmacology, Hope Center for Neurological Disorders, Washington University, St. Louis, Missouri (L.W., B.H.H., D.M.H.); and Department of Manufacturing Pharmacy, Seoul National University, Seoul, South Korea (B.H.H.)

Cell death induced by the combined insult of hypoxia-ischemia in neonatal rodents has been extensively investigated. Ischemia-only-induced cell death, however, has been much less characterized. Based on the notion that 1) ischemic stroke is a relatively common disorder in human neonates, and 2) developing cells are more susceptible to apoptosis, the present study examined whether typical apoptosis was induced by cerebral ischemia in a new neonatal rat model. Erythropoietin (EPO; Epoetin) was tested for its protective effect against ischemia-induced cell death. Postnatal day 7 rats were subjected to permanent occlusion of the middle cerebral artery branch supplying the right whisker-barrel cortex. Terminal deoxynucleotidyl transferase biotin-dUTP nick end-labeled-positive cells in the ischemic region were detectable 4 h after ischemia and reached a peak level 16 h later. The cell death was preceded by caspase activation and cytochrome c release. Cell body shrinkage was evident among damaged cells. Agarose gel electrophoresis showed DNA damage with a smear pattern as well as DNA laddering. Electron microscopy demonstrated apoptotic features such as cell shrinkage, chromatin condensation, and fragmentation; meanwhile, necrotic alterations coexisted in the cytoplasm. EPO treatment increased signal transducers and activators of transcription-5 and Bcl-2 levels, markedly attenuated apoptotic cell death, and reduced ischemic infarct in the cortex. It is suggested that focal ischemia in the developing brain causes cell death with prominent apoptotic features coexisting with some characteristics of necrosis. This is consistent with the concept of hybrid death described previously in cultures and adult or developing brain. EPO may be explored as a potential therapy for neonatal ischemic stroke.


Received August 18, 2005; accepted December 14, 2005.

Address correspondence to: Dr. Shan Ping Yu, Department of Pharmaceutical Sciences, 280 Calhoun St., Medical University of South Carolina, Charleston, SC 29425. E-mail: yusp{at}musc.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. L. Keogh, S. P. Yu, and L. Wei
The Effect of Recombinant Human Erythropoietin on Neurovasculature Repair after Focal Ischemic Stroke in Neonatal Rats
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 521 - 528.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.